C-Reactive Protein and Lymphocyte-to-Monocyte Ratio Predict Recurrence in Stage III Melanoma Patients with Microscopic Sentinel Lymph Node Metastasis

C-Reactive Protein and Lymphocyte-to-Monocyte Ratio Predict Recurrence in Stage III Melanoma Patients with Microscopic Sentinel Lymph Node Metastasis

Although adjuvant therapies with immune checkpoint inhibitors (ICI) and BRAF/MEK inhibitors improve recurrence-free survival (RFS) in stage III melanoma patients significantly, prognostic factors are needed to identify patients with a high risk of disease recurrence. Therefore, the aim of our study...

Full description

Bibliographic Details
Main Authors: Viktoria Anna Sophie Schildbach, Susanne Horn, Guillermo Hidalgo-Gadea, Wibke Johannis, Cornelia Mauch, Cindy Franklin
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Cancers
Subjects:
C-reactive protein (CRP)
lymphocyte-to-monocyte ratio (LMR)
neutrophil-to-lymphocyte ratio (NLR)
derived NLR
platelet-to-lymphocyte ratio (PLR)
melanoma
Online Access:https://www.mdpi.com/2072-6694/15/3/702

Internet

https://www.mdpi.com/2072-6694/15/3/702

Similar Items